Investing Ideas
/
Malaysian Pharmaceuticals & Biotech Healthy potentially undervalued

Malaysian Pharmaceuticals & Biotech Healthy potentially undervalued

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.23

-10.9%